Arbutus Biopharma ABUS
NASDAQ ABUS
$3.83 +0.11 (+2.82%)
As of: Nov 10, 2026 · 3:59 PM EST

Arbutus Biopharma (ABUS) Other financing activities (as filed) (2019)

Updated

Arbutus Biopharma (ABUS) reported Other financing activities of $18.55 million for FY2019.

Analysis

Arbutus Biopharma (ABUS) Other financing activities (as filed) (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Arbutus Biopharma 755.33 Mn 382.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 18.55 Mn
API Access

Arbutus Biopharma Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ABUS&period=max&api_key=YOUR_API_KEY